Hello there! Want a discount? Grab 5% OFFon your first order!
originalresearchpapers.com logo
Hello there! Want a discount? Grab 5% OFF on your first order!
originalresearchpapers.com logo

Top of Form Ashley Evans Health Care Informatics-DAX-DL01 Prof. Deborah CrevecoeurDiscussion Week 3 “The FDA’s mobile medical

Top of Form

Ashley Evans

Health Care Informatics-DAX-DL01

Prof. Deborah Crevecoeur

Discussion Week 3

“The FDA’s mobile medical apps policy does not
 regulate the sale or general consumer use of smartphones or tablets” (I.Sim, 2019). The FDA’s mobile medical apps policy does not
 consider entities that exclusively distribute mobile apps, such as the owners and operators of mobile application stores to be medical device manufacturers. This is beneficial due to the FDA’s mobile medical apps policy does not consider mobile platform manufacturers to be medical device manufacturers just because their mobile platform could be used to run a mobile medical app regulated by the FDA.

However, the FDA regulates mobile medical apps through a systematic approach that ensures their safety and effectiveness. This process includes identifying medical apps, categorizing risks, and implementing a regulatory framework that encompasses pre-market review and post-market monitoring. This approach strikes a balance between fostering innovation and protecting public health. “By establishing quality standards and raising awareness, the FDA plays a vital role in encouraging the development of dependable mobile medical apps that serve the public interest while minimizing the potential risks of their usage” (FDA.gov, 2022).

Software functions that qualify as a device can be implemented on mobile platforms, other general-purpose computing platforms, or as part of the functionality or control of a hardware device. The FDA’s policies, which are platform-independent and function-specific, are consistently applied across different platforms. The term “software functions” encompasses mobile applications (apps).

How does the FDA regulate device software functions?

The FDA applies the same risk-based approach to device software functions as the agency uses to assure safety and effectiveness for other medical devices.

In conclusion, mobile apps can help people manage their own health and wellness, promote healthy living, and gain access to useful information when and where they need it. These tools are being adopted almost as quickly as they can be developed. Users include health care professionals, consumers, and patients.

The FDA encourages the development of mobile medical apps (MMAs) that improve health care and provide consumers and health care professionals with valuable health information. The FDA also has a public health responsibility to oversee the safety and effectiveness of medical devices including mobile medical apps.

References

Device software functions and mobile medical applications. (2022, September 29). U.S. Food and Drug Administration. 

Sim, I. (2019, September 4). 
Just a moment... Just a moment… 

Bottom of Form

Edited by Ashley Evans on Sep 18, 2024, 4:42:30 PM


Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

COMPLETE QUESTIONS Thumbnails/thumbnail.png1) Codes 20900–20938 for grafts (or implants) are reported when __________ tissue (originating in

COMPLETE QUESTIONS  Thumbnails/thumbnail.png 1) Codes 20900–20938 for grafts (or implants) are reported when __________ tissue (originating in the patient’s body) is obtained through separate skin or fascial incisions. Responses allogenous allogenous rhytid rhytid osteogenesis osteogenesis autogenous autogenous 2) A patient suffered a traumatic complete amputation of the left forearm in

COMPLETE QUESTION BY FILLING IN THE BLANKThumbnails/thumbnail.png1) Sepsis due to E.

COMPLETE QUESTION BY FILLING IN THE BLANK Thumbnails/thumbnail.png 1) Sepsis due to E. coli. Responses A41.4 A41.50 A41.51 A41.9 2) Metastatic carcinoma from the lung. Responses D49.9, C80.1 D49.9, C34.90 C79.9, D49.1 C34.90, C79.9 3) ype 2 diabetes mellitus with diabetic macular edema and retinopathy, right eye, resolved following treatment. Responses

COMPLETE IN DETAILThumbnails/thumbnail.png1) Opioid use, abuse, and dependence with intoxication and delirium FILL IN BLANK2) Paranoid

COMPLETE IN DETAIL Thumbnails/thumbnail.png 1) Opioid use, abuse, and dependence with intoxication and delirium FILL IN BLANK 2) Paranoid schizophrenia FILL IN BLANK 3) Alcoholic delirium tremens FILL IN BLANK 4) Factitious disorder, imposed on self, with predominantly physical signs and symptoms FILL IN BLANK 5) Major depressive disorder, recurrent, with psychotic

  Past ExperienceI work on a peds Oncology hematology floor.Describe your

  Past Experience I work on a peds Oncology hematology floor. Describe your experience in the utilization of nursing research in your clinical practice.   Submission Instructions: · Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic

PLEASE READ CAREFULLY ATTACHED DOCUEMTN FOR ALL INSTRUCTIONS AND REQUIREMENTSAdvanced Practice Nursing: Clinical Decision-Making and Leadership

PLEASE READ CAREFULLY ATTACHED DOCUEMTN FOR ALL INSTRUCTIONS AND REQUIREMENTS Advanced Practice Nursing: Clinical Decision-Making and Leadership Essay Overview: This assignment invites you to explore the evolution of clinical decision-making as you transition from bedside nursing to advanced practice roles. In your essay, you will critically analyze and compare the

Module 1 Discussion  Foundation for Health Promotion For this Discussion, your

Module 1 Discussion   Foundation for Health Promotion For this Discussion, your instructor will assign you a case number. Case  Cases D.H. is a nurse administrator at a large primary practice. His duties include maintaining the nurses’ schedules to keep within the facility’s budget; overseeing the hiring and training of

You deserve a bonus!

Subscribe and get regular bonuses and discounts.